Ultragenyx Pharmaceutical | RARE - Odsetki Od Długu





Odsetki Od Długu Zmiana Data
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Immunic 197K 222K 2025-12
Insmed USD 20.41M 1.57M 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Kyowa Hakko Kirin JPY 92M 2.18B 2026-09
MacroGenics USD 4.4M 493K 2026-06
Moderna USD 10.96B 527M 2026-06
Neurocrine Biosciences USD 300K 2.6M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09